CClinicalTrials.gg
CompletedNCT06973460ROB-BSTUpdated Jul 7, 2026

Robotic-Assisted System in Enhancing Balance, Postural Stability, Functional Gait and Fall Efficacy in Older Adults

An interventional study of Robotic Assisted System and Otago Exercise Programme in Aged, Aged Healthy Volunteer and Geriatric, sponsored by Gulf Medical University. Completed at 1 site in United Arab Emirates. Open to participants aged 60 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-07.

Sponsored by Gulf Medical University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Jan 2025, registered May 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
60 Years to 85 Years
Sex
All
01

Study summary

Our study aims to investigate the effectiveness of a more individualized and personalized feedback-oriented approach using a Robotic Assisted System, the Hunova Movendo Robotic System. This system is tailored to specific needs of individuals and is dynamically adjustable relative to patients' balance and functional demands. It will be compared to Otago Exercise Programme which is more generalized. Given the generalized nature of the Otago Exercise Programme, we aim to compare it with the Robotic Assisted Systems in the enhancement of Balance, Postural Stability, Functional Gait and Fall Efficacy in older adults.

Read the detailed description

Aging comes with increased risk of fall and a steep decline in adequate motor functioning, as such due to the decline in proprioception, balance and general functional independence the risk of falls and injury is high in aging adults impacting quality of life.

Traditional approaches like the Otago Exercise Programmes (and other Balance and Mobility exercise protocols) have been relatively effective in the management of falls yet there's a remarkable and persistent increase in fall rates, postural instability and functional gait limitations in older adults largely due to the generalized nature of these protocols. The limitations of these traditional approaches in individualizing treatment protocols created a need for advanced and more dynamic systems that can fill this gap and/or complement these traditional approaches.

Modern Technology, including Hunova Robotic systems are novel approaches that seek to solve these limitations by tailoring interventions to patients' needs creating real time feedback mechanisms assisting in intervention prescriptions and analysis. The preciseness of these modern systems assist in creating integrated systems that enhance organization of these interventions improving overall outcomes.

Literature supporting the use of the Robotic Assisted Systems on Fall efficacy, postural stability and functional gait is very limited, necessitating a need for studies comparing the effectiveness of this technology on these components compared to Otago Exercise Programme. This research aims to investigate the effectiveness of a Robotic Assisted System in improving fall efficacy, postural stability and functional gait in older adults and in general geriatric rehabilitation. With the increased emphasis on robotic-assisted rehabilitation due to its accuracy, individualized patient focused design and feedback mechanisms, the study becomes all the more imperative.

This Research attempts to compare the Robotic Assisted System on Fall Efficacy, Functional Gait and postural stability with Otago Exercise Programme.

02

Conditions studied

  • Aged
  • Aged Healthy Volunteer
  • Geriatric
  • Balance
  • Fall Risk, Fall Prevention

Keywords

  • Robotic System
  • Hunova
  • Balance
  • Older Adults
  • Fall Efficacy
  • Functional Gait
  • Robotic-assisted System
  • Balance and Mobility Exercise
  • Otago Exercise Programme
03

In context

Lead sponsor

Gulf Medical University is the lead sponsor of 40 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 60 years old to 85 years old - young to Old Individuals.
  • Mini Mental Scale Examination Score > 24.
  • Able to walk independently with and without mild assistance (Berg's Balance Score between 35 and 45)

Exclusion criteria

Exclusion Criteria:

  • Unable to understand and follow instructions.
  • History of vestibular dysfunction.
  • Any severe Musculoskeletal problems restricting mobility.
  • Current Physiotherapy training or balance exercises focusing on proprioception or fall risk.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    Robotic Assisted Group Using the Hunova Movendo Robotic Device.

    Balance Training on Robotic Assisted System: Bipodalic Stance: On Static platform; Elastic Platform, Fluid platform, Wobble Base, Balance on variable counter resistance platform, Sagittal Lunges. Monopodalic (Left \& Right): On Static platform; Elastic Platform, Fluid platform, Wobble Base, Balance on variable counter resistance platform, Isometric Ankle. Strengthening: Balance on Counter-resistance platform, raises, Ping Pong on Elastic platform, Bipodalic Sit to Stand Mobility and Gait: Bipodalic Stance: Balance on Elastic Platform, Balance on Fluid Platform, Balance on Proprioceptive Platform, Balance on Linear PAssive Combined Passive platform, Balance on Passive Spiral Base. In addition: Stair walking on standardized stairs. Rest Period: 5 mins incorporated in between intervention. Duration : 45 minutes/day Frequency: 2 days per week for a period of 12 weeks

    Device: Robotic Assisted System

  • Active comparator
    Otago Exercise Programme

    * Strengthening Training: * Knee Extensor * Knee Flexor * Hip Adductor * Ankle plantarflexors (calf Raises) * Ankle dorsiflexors (toe raises) * Balance Training: * Knee Bends * Backwards walking * Walking and turning around * Sideways walking * Tandem Stance (heel toe stand) * Tandem Walk (Heel toe Walk) * One Leg Stand * Heel walking * Toe Walk * Heel Toe Walking backwards * Sit to Stand * Stair walking Rest Period: 5mins incorporated in-between intervention. Duration : 45 minutes/day Frequency: 2 days per week for a period of 12 weeks

    Other: Otago Exercise Programme

Interventions

  • DeviceRobotic Assisted System

    Hunova Movendo Robotic System

  • OtherOtago Exercise Programme

    Otago Exercise Programme

06

What researchers measure

Primary outcomes

  1. Hunova Evaluation Tools:

    Hunova's precise assessment tools assist clinicians tailor prevention interventions with Quantitative data. Assessment Domains: Static \& dynamic postural control Visual dependency in balance (Romberg Index) Trunk stability Functional sit-to-stand transitions Limits of stability Scoring: No single cumulative score; results are reported through individual biomechanical parameters such as: Sway Area (cm²) (CE,OE) COP Path Length (cm) (CE,OE) Romberg Index (unitless ratio) Trunk Oscillation Range (deg) (multi directionally) (CE,OE) 5x Sit-to-Stand Duration (seconds) Limits of Stability (LoS) (cm) (Max COP \& LEAN multi directionally). Interpretation: Lower values (individualized normative values) in Sway Area, Path Length, \& Romberg Index indicate better balance, greater postural control, \& lower fall risk. Higher values (individualized normative values) in Trunk Oscillation, LoS \& Sit-to-Stand times reflect reduced functional stability \& potential impairments in dynamic control.

    Time frame: Baseline and 12 weeks

Secondary outcomes

  1. Berg's Balance Scale (BBS)

    A Gold Standard in the assessment of Balance Impairments Score range: 0 to 56 Interpretation: Higher scores indicate better balance and lower fall risk.

    Time frame: Baseline and 12 weeks

  2. Star Excursion Balance Test (SEBT)

    This test assesses dynamic balance by measuring reach distance while balancing on one leg in various directions. Used to detect deficits in balance and flexibility, it has an interrater reliability and has been validated in the identification of balance deficits in lower extremity. It is useful in assessment of the functional strength of older adults as they're prone to balance, proprioception and flexibility decline. Range: Reach distance measured in centimeters; often normalized to leg length. Intepretation: Greater reach distance indicates better dynamic postural control.

    Time frame: Baseline and 12 weeks

  3. Functional Gait Assessment (FGA):

    FGA is an assessment scoring scale that measures gait stability under different conditions and tasks. It ranges from 0-30. Lower scores signify higher gait impairments. It has an interrater reliability (ICC \> 0.9). It also has high sensitivity to functional gait changes supporting its use care in baseline and follow up assessments in Older Adults

    Time frame: Baseline and 12 weeks

  4. Fall Efficacy Scale- International (FES-I):

    FES-I is a 16 to 64 self-reporting tool that is used to assess confidence in performing activities without the risk of fall. Higher scores signify a greater fear of falling. It gives insight on how much the fear of falling influences activities. It has an internal consistency (Cronbach's Alpha \> 0.9) suggesting reliability and validity in research

    Time frame: Baseline and 12 weeks

07

Study locations

1 site
  • Thumbay Physical Therapy and Rehabilitation Hospital
    Ajman, United Arab Emirates
08

References and documents

Individual participant data

Plan to share: No — Data might be shared based on the request

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06973460
Lead sponsor
Gulf Medical University
Responsible party
Sponsor
First posted
May 15, 2025
Start date
Jan 1, 2025
Primary completion
Jun 15, 2025
Completion
Jun 30, 2025
Last update
Jul 7, 2026

Study contacts

Meruna Bose, PHD
study chair · Gulf Medical University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion